Showing results (1311-1320 of 1,350) with videos related to

Sort By:
Pageof 135
Cancer Research and Treatment|July 4, 2023
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean SubsetKi Hyeong Lee, Byoung Chul Cho, Myung-Ju Ahn, et al.
The EMBO Journal|April 14, 2019
Co-degradation of interferon signaling factor DDX3 by PB1-F2 as a basis for high virulence of 1918 pandemic influenzaEun-Sook Park, Young Ho Byun, Soree Park, et al.
Gut|November 19, 2020
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitisEun Hee Koh, Ji Eun Yoon, Myoung Seok Ko, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 10, 2021
Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 InflammasomeChung Hwan Hong, Myoung Seok Ko, Jae Hyun Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2021
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase InhibitorsByoung Chul Cho, Ji-Youn Han, Sang-We Kim, et al.
Rheumatology International|January 30, 2017
Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritisYoon-Kyoung Sung, Soo-Kyung Cho, Dam Kim, et al.
Nature Communications|November 23, 2024
Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironmentKyu Jin Song, Seunghyuk Choi, Kwoneel Kim, et al.
Pageof 135